Baylor College of Medicine News

Pediatric Cancer News

Pediatric oncologist receives grant for neuroblastoma researchJul 10, 2013
Dr. Jason Shohet has received a grant from Braden’s Hope for Childhood Cancer to support his research to find novel treatments for high-risk neuroblastoma.
Phase 1 trial uses enhanced T cells to treat neuroblastomaJun 10, 2013
A phase 1 clinical trial at Baylor College of Medicine, which has received support from a pediatric cancer nonprofit organization, will use an immunotherapy approach to treating kids with neuroblastoma.
Grant funds research to study new treatments for osteosarcomaMay 2, 2013
The grant funds research focused on the highest risk and the poorest outcome cancers in children.
BCM receives grants from Rally Foundation for childhood cancerApr 23, 2013
All grants are made in honor or memory of a Rally Kid, a child who has fought or is currently fighting cancer.
Baylor College of Medicine receives $350K in Avon grants for breast cancer care, researchApr 23, 2013
The grants were presented at the closing ceremonies of the 6th annual Avon Walk for Breast Cancer Houston April 21.
BCM major part of new pediatric cancer Dream Team initiativeApr 13, 2013
Pediatric Dream Team Translational Cancer Research Project will provide a total of $14.5 million over four years, with $3.3 million to BCM.
Grant to support pediatric cancer research in South TexasFeb 19, 2013
The one-year, $80,670 grant is part of a series of grants from the foundation to institutions to boost pediatric cancer research.
Grant funds developmental therapeutics program at BCMJan 29, 2013
Alex's Lemonade Stand Foundation grant awarded to Texas Children's Cancer Center to improve treatment, find cures for childhood cancer.
Vegetable compound could become ingredient to treating leukemiaDec 12, 2012
BCM study finds concentrated form of compound found in broccoli reduces the number of acute lymphoblastic leukemia cells.
Grant supports Gottschalk's osteosarcoma immunotherapy researchNov 13, 2012
Research will focus on using patient's immune system, genetic approach to fight their cancer.